Bisphosphonates Pamidronate and Zoledronic Acid Stimulate Osteoprotegerin Production by Primary Human Osteoblasts
- 1 March 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 291 (3), 680-686
- https://doi.org/10.1006/bbrc.2002.6510
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Alendronate for the Treatment of Osteoporosis in MenThe New England Journal of Medicine, 2000
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during ApoptosisJournal of Biological Chemistry, 1999
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitoninJCI Insight, 1999
- Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate TreatmentThe New England Journal of Medicine, 1998
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisThe New England Journal of Medicine, 1998
- Tiludronate inhibits interleukin-6 synthesis in osteoblasts: Inhibition of phospholipase D activation in MC3T3-E1 cellsJournal of Cellular Biochemistry, 1998
- Bisphosphonates Stimulate Formation of Osteoblast Precursors and Mineralized Nodules in Murine and Human Bone Marrow Cultures In Vitro and Promote Early Osteoblastogenesis in Young and Aged Mice In VivoBone, 1998
- Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitorsJournal of Cellular Biochemistry, 1998
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisThe New England Journal of Medicine, 1995